Northern Trust
PYXS icon

Northern Trust’s Pyxis Oncology PYXS Stock Holding History

Northern Trust’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Buy
123,959
+22,011
+22% +$42.1K ﹤0.01% 3743
2026
Q1 		$149K Hold
101,948
– – ﹤0.01% 4019
2025
Q4 		$117K Buy
101,948
+1,175
+1% +$4.14K ﹤0.01% 4107
2025
Q3 		$224K Sell
100,773
-1,443
-1% -$2.08K ﹤0.01% 3946
2025
Q2 		$112K Sell
102,216
-271,500
-73% -$306K ﹤0.01% 4087
2025
Q1 		$366K Sell
373,716
-4,870
-1% -$6.5K ﹤0.01% 3703
2024
Q4 		$591K Sell
378,586
-15,449
-4% -$44.6K ﹤0.01% 3597
2024
Q3 		$1.45M Buy
394,035
+265,639
+207% +$930K ﹤0.01% 3182
2024
Q2 		$425K Buy
128,396
+67,162
+110% +$282K ﹤0.01% 3567
2024
Q1 		$261K Buy
61,234
+951
+2% +$4K ﹤0.01% 3801
2023
Q4 		$109K Buy
60,283
+7,537
+14% +$12.9K ﹤0.01% 4095
2023
Q3 		$105K Buy
52,746
+5,353
+11% +$12.4K ﹤0.01% 4002
2023
Q2 		$121K Buy
47,393
+15,886
+50% +$50.4K ﹤0.01% 3985
2023
Q1 		$126K Buy
31,507
+5,109
+19% +$10.2K ﹤0.01% 4021
2022
Q4 		$35.4K Hold
26,398
– – ﹤0.01% 4367
2022
Q3 		$52K Buy
26,398
+8,656
+49% +$22.6K ﹤0.01% 4313
2022
Q2 		$42K Sell
17,742
-70,587
-80% -$188K ﹤0.01% 4455
2022
Q1 		$357K Sell
88,329
-906
-1% -$6.62K ﹤0.01% 3875
2021
Q4 		$979K Buy
+89,235
New +$1.02M ﹤0.01% 3546

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust's PYXS Position: Q2 2026 in Review

Northern Trust increased its Pyxis Oncology (PYXS) stake by 22% in Q2 2026, buying an estimated $42.1K and bringing the position to 123,959 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #3743.

Northern Trust first reported a position in PYXS in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.45M in Q3 2024. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Northern Trust held 123,959 shares of Pyxis Oncology worth $373K as of Q2 2026.
  • Northern Trust bought 22,011 Pyxis Oncology shares in Q2 2026, an estimated $42.1K.
  • Pyxis Oncology made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3743 holding.
  • Northern Trust first reported a position in Pyxis Oncology in Q4 2021 and has held it in 19 quarters since.
  • Northern Trust's Pyxis Oncology position peaked at $1.45M in Q3 2024.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.